However, most of the studies that have assessed copeptin in stroke patients have focused on ischemic stroke and the prognostic value of this marker for stroke severity, treatment efficacy, stroke complications, functionality, mortality, and recurrence [25]. The gene discussed is AVP; the disease is stroke disorder.